Soranib Sorafenib 200 Mg Tablets

Get a Price/Quote

MOQ : 10 Pieces

Soranib Sorafenib 200 Mg Tablets Specification

Salt Composition
Sorafenib 200 mg

Dosage Form
Tablet

Indication
Used for the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma (DTC)

Feature
Targeted therapy, Multi-kinase inhibitor

Ingredients
Sorafenib Tosylate

Application
Oral use, prescription-only anti-cancer medication

Physical Color/Texture
Tablet form, film-coated, usually light colored

Storage Instructions
Store below 30C, protect from moisture and light

Shelf Life
24 months from the date of manufacture

Route of Administration
Oral

Patient Information Leaflet
Included in the packaging

Marketed By
Cipla Ltd.

Regulatory Status
Approved for use in India

Strength
200 mg per tablet

Packaging Size
120 tablets per bottle

Warning
To be used under medical supervision only

Prescription/Non-prescription
Prescription only

Trade Name
Soranib

Soranib Sorafenib 200 Mg Tablets About

Discover the noble efficacy of Soranib Sorafenib 200 Mg Tablets, featured in a substantial 120-tablet bottle for reduced monthly expenditure. Proudly marketed by Cipla Ltd. and approved for use in India, this incomparable, prescription-only oral medication delivers astounding results in managing advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma (DTC). Each film-coated, light-colored tablet harnesses the targeted multi-kinase inhibitor strength of Sorafenib Tosylate. A comprehensive patient leaflet is included. Always buy and use under trusted medical supervision for optimal safety.

Application Areas & Distinct Features

Soranib Sorafenib 200 Mg Tablets are ideally utilized for the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and differentiated thyroid carcinoma (DTC). With its sophisticated multi-kinase inhibitor mechanism, this targeted therapy ensures a focused approach to cancer care. Designed for prescription-only, oral use, Soranib stands out for its incomparable efficacy and patient safety. Its film-coated, light-colored tablets are formulated for straightforward usage and optimal absorption.

Delivery, Supply Chain, and Certifications

The supply of Soranib Sorafenib 200 Mg Tablets is operational via India's major FOB ports, with robust goods transport ensuring timely delivery to clients. Soranib's high supply ability meets the demands of healthcare providers without compromising product integrity. Expenditure on these certified products becomes a worthwhile investment, as Soranib maintains stringent regulatory compliance and assurance in every delivery cycle, supporting healthcare environments across the country.

FAQ's of Soranib Sorafenib 200 Mg Tablets:

Q: How should Soranib Sorafenib 200 Mg Tablets be taken?

A: Soranib should be taken orally, precisely as prescribed by your healthcare provider. It is crucial not to alter the dosage without medical advice and to follow all instructions provided in the patient information leaflet.

Q: What are the main benefits of using Soranib for cancer treatment?

A: Soranib offers targeted therapy, specifically inhibiting multiple kinases involved in cancer cell growth. This action makes it highly beneficial for treating advanced RCC, HCC, and DTC, with the focus on maximizing efficacy while minimizing harm to healthy cells.

Q: When is Soranib indicated for use?

A: Soranib is indicated for patients diagnosed with advanced renal cell carcinoma, hepatocellular carcinoma, or differentiated thyroid carcinoma, particularly when traditional treatments are not effective or suitable.

Q: Where is Soranib manufactured and marketed?

A: Soranib Sorafenib 200 Mg Tablets are manufactured and marketed by Cipla Ltd., a reputable pharmaceutical company in India, and are approved for use within the country.

Q: What is the process for storing Soranib Sorafenib tablets safely?

A: Soranib should be stored below 30C in its original packaging, away from moisture and light, to maintain its effectiveness and shelf life of 24 months from the date of manufacture.